Inceptive
PrivateLast Round
Strategic
Jun 3, 2026
Est. Valuation
$300M
Total Funding Raised
$120M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Inceptive operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a Series A round in September 2023.
Inceptive is a biotechnology company that develops an AI-powered biological software platform for the design and creation of synthetic RNA molecules and novel therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inceptive Comparables
Compare Inceptive with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atomic AI | 86% | |
| Deep Genomics | 85% | |
| Insitro | 78% |
For institutional investors. Book with your work email.
Inceptive Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 3, 2026 | ||||
| Series A | Sep 6, 2023 | ||||
| Seed | Jan 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Inceptive Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A |
| S32 | Series A |
| Obvious Ventures | Series A |
| NVentures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 42% MoM, reaching 7.3K.
- Jan 1, 2022
$20M round raised at $100M post-money valuation.
For institutional investors. Book with your work email.
Inceptive Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inceptive's valuation, stock price, and market status.
Is Inceptive a public or private company?
Inceptive is a private company.
What is the current stock price of Inceptive?
Inceptive is a private company, so its shares have no public market price. Caplight tracks Inceptive's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inceptive worth (valuation)?
Inceptive's valuation is estimated at $300.0M based on funding round data.
Can I buy Inceptive stock?
Inceptive shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inceptive's last funding round?
Inceptive's most recent funding round was Strategic on June 3, 2026.
Who are the main investors in Inceptive?
Key investors in Inceptive include Andreessen Horowitz, NVentures.
Will Inceptive IPO soon?
No public IPO plans have been announced for Inceptive.
How can I track Inceptive secondary market activity?
Caplight tracks bids, offers, and trades in Inceptive's shares on secondary markets.